ARCHIVES

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

This article is from The Cancer Letter archive.

Vol. 34 No. 38 | October 17, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

NCI-Approved Clinical Trials

June 25, 2004

Conversation with The Cancer Letter: Einhorn: “I Still Harbor Hope For Similar Success Stories”

October 24, 2014

Resource Offered for DNA Probe Mapping

August 14, 1987

In Brief: WHO Begins Project To Urge Governments To Establish “National Cancer Programs”

October 30, 1998

Faulty Estimates Led NCI To Overstate Black-White Cancer Disparity In Atlanta

September 20, 2002